#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17118	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2344	894.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1821	1821	T	1109	T,A	1108,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17118	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2344	894.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1555	1555	C	1094	C	1094	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29322	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3950	926.5	0	.	n	.	0	T695C	SNP	695	695	T	1210	1210	C	1060	C	1060	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29322	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3950	926.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	2153	2153	G	1129	G	1129	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29322	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3950	926.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2486	2486	C	1064	C,T	1063,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29322	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3950	926.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2560	2560	A	970	A	970	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29322	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3950	926.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3112	3112	C	1037	C,A	1036,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29322	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3950	926.5	0	HET	.	.	.	C167T,G,A	.	167	167	C	682	682	C	1143	C,T,G,A	848,293,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29322	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3950	926.5	0	HET	.	.	.	G1969C	.	1969	1969	G	2484	2484	G	1053	G,C	582,471	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	2434	folP	852	852	100.0	folP.l15.c4.ctg.1	1999	151.9	1	SNP	p	R228S	0	.	.	682	684	CGC	1293	1295	CGC	243;244;244	C;G;C	243;244;244	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5844	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	3900	187.2	1	SNP	p	S91F	0	.	.	271	273	TCC	883	885	TCC	232;232;233	T;C;C	232;232;233	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5844	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	3900	187.2	1	SNP	p	D95G	0	.	.	283	285	GAC	895	897	GAC	241;240;241	G;A;C	241;240;241	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5844	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	3900	187.2	1	SNP	p	D95N	0	.	.	283	285	GAC	895	897	GAC	241;240;241	G;A;C	241;240;241	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	2106	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1842	142.8	1	SNP	p	G45D	1	.	.	133	135	GAC	664	666	GAC	263;266;263	G;A;C	263;266;263	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1182	mtrR_promoter	250	250	99.2	mtrR_promoter.l6.c30.ctg.1	1328	110.4	0	.	n	.	0	T10C	SNP	10	10	T	589	589	C	202	C	202	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1182	mtrR_promoter	250	250	99.2	mtrR_promoter.l6.c30.ctg.1	1328	110.4	0	.	n	.	0	A197.	DEL	197	197	A	775	775	A	239	A	239	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	6040	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3319	227.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1834	1836	GCA	296;296;297	G,A;C;A	295,1;296;297	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	6040	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3319	227.2	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2317	2319	ATT	305;309;305	A,C;T;T	304,1;309;305	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	6040	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3319	227.2	1	SNP	p	D86N	0	.	.	256	258	GAC	787	789	GAC	278;277;280	G,A;A,C;C	277,1;276,1;280	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	6040	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3319	227.2	1	SNP	p	S87W	0	.	.	259	261	AGT	790	792	AGT	282;284;285	A;G;T	282;284;285	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	6040	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3319	227.2	1	SNP	p	S87I	0	.	.	259	261	AGT	790	792	AGT	282;284;285	A;G;T	282;284;285	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	6040	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3319	227.2	1	SNP	p	S87R	0	.	.	259	261	AGT	790	792	AGT	282;284;285	A;G;T	282;284;285	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	6040	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3319	227.2	1	SNP	p	S88P	0	.	.	262	264	TCC	793	795	TCC	290;292;288	T,C;C;C,T	289,1;292;286,2	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4778	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3030	196.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1728	1730	GGC	303;300;299	G;G;C	303;300;299	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4714	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2744	214.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1430	1432	GCA	276;277;279	G;C;A	276;277;279	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4714	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2744	214.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1433	1435	ATC	281;280;283	A;T,G;C	281;278,2;283	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4714	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2744	214.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1445	1447	GTG	285;289;287	G;T;G	285;289;287	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4714	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2744	214.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1445	1447	GTG	285;289;287	G;T;G	285;289;287	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4714	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2744	214.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1949	1951	ACC	286;286;283	A;C;C	286;285;283	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4714	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2744	214.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2003	2005	GCG	281;282;281	G;C,G,A;G	281;280,1,1;281	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4714	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2744	214.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2003	2005	GCG	281;282;281	G;C,G,A;G	281;280,1,1;281	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4714	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2744	214.2	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2126	2128	GGT	272;273;273	G;G;T	272;273;273	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4714	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2744	214.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2135	2137	GGC	278;277;278	G;G;C,T	278;277;277,1	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4714	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2744	214.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2153	2155	CCG	278;277;277	C,T;C;G,T	277,1;277;276,1	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6140	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3482	220.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1819	1821	CCG	248;246;246	C,G;C,T,G;G,A	245,2;244,1,1;245,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2812	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2284	153.8	0	.	p	.	0	S22G	NONSYN	64	66	AGC	674	676	GGC	198;197;198	G,T;G;C	197,1;197;198	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2812	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2284	153.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	856	856	C	212	C	212	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3402	porB1b	1047	1047	99.81	porB1b.l15.c30.ctg.1	1616	254.8	0	.	p	.	0	G120D	NONSYN	358	360	GGC	788	790	GAC	264;264;266	G;A;C	264;264;266	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3402	porB1b	1047	1047	99.81	porB1b.l15.c30.ctg.1	1616	254.8	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	791	793	AAC	266;265;263	A;A;C	266;265;263	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11434	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	5355	266.5	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2131	2133	CAT	292;293;292	C;A;T,G	292;293;291,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1602	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1611	124.0	1	SNP	p	V57M	0	.	.	169	171	GTG	763	765	GTG	283;283;281	G;T,G;G,T	283;282,1;280,1	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
